Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|January 27, 2024
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cellsMikel Gurrea-Rubio, Qi Wu, M Asif Amin, et al.
Research Square|October 27, 2023
Activation of Cytotoxic Lymphocytes Through CD6 Enhances Killing of Cancer CellsMikel Gurrea-Rubio, Qi Wu, M Asif Amin, et al.
JCI Insight|March 29, 2022
Inhibition of bromodomain extraterminal histone readers alleviates skin fibrosis in experimental models of sclerodermaSirapa Vichaikul, Mikel Gurrea-Rubio, M Asif Amin, et al.
Nature Communications|January 3, 2024
Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosisFeiyang Ma, Pei-Suen Tsou, Mehrnaz Gharaee-Kermani, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 23, 2024
Targeting CD13/Aminopeptidase N as a Novel Therapeutic Approach for Scleroderma FibrosisSei Muraoka, William D Brodie, Megan N Mattichak, et al.
The Journal of Clinical Investigation|December 5, 2023
Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativaKelsey R van Straalen, Feiyang Ma, Pei-Suen Tsou, et al.
The Journal of Clinical Investigation|April 19, 2022
Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1Pei-Suen Tsou, Chenyang Lu, Mikel Gurrea-Rubio, et al.
JCI Insight|April 1, 2025
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infectionPei-Suen Tsou, Ramadan A Ali, Chenyang Lu, et al.
Pageof 1